Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: Specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 6, 2001, Pages 1033-1037

  Girard, Philippe ^a   Decousus, Marielle ^b   Laporte, Silvy ^b   Buchmuller, Andrea ^b   Hervé, Philippe ^b   Lamer, Christian ^b   Parent, Florence ^b   Tardy, Bernard ^b  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

^b NONE

Author keywords

Diagnosis; Pulmonary angiography; Pulmonary embolism; Radionuclide imaging; Sensitivity and specificity; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INCIDENCE; LEG PHLEBOGRAPHY; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0035883702     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.6.2101045     Document Type: Article

References (33)

1. Is embolic risk conditioned by location of deep venous thrombosis?
2. Occult pulmonary embolism: A common occurrence in deep venous thrombosis
3. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis
4. Asymptomatic pulmonary embolism in patients with deep vein thrombosis. Is it useful to take a lung scan to rule out this condition?
5. Deep venous thrombosis and the risk of pulmonary embolism. A systematic study
6. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis
7. Pulmonary embolism and the level of thrombosis. A prospective study of 155 patients
8. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin
9. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis
10. Antithrombotic therapy for venous thromboembolic disease
11. Silent pulmonary embolism
12. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis
13. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis
14. Spurious scintiphotographic recurrence of pulmonary emboli
15. Recurrence of pulmonary embolism during anticoagulant treatment: A prospective study
16. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
17. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
18. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan
19. Diagnostic utility of ventilation/perfusion lung scans in acute pulmonary embolism is not diminished by pre-existing cardiac or pulmonary disease
20. Diagnosing acute pulmonary embolism: Effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography
21. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism
22. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals
23. Non-invasive diagnosis of venous thromboembolism in outpatients
24. Pulmonary embolism
25. Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: A prospective study
26. Inferior vena cava filters. Indications,safety, effectiveness
27. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
28. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
29. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents
30. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease
31. Accuracy of clinical assessment in the diagnosis of pulmonary embolism
32. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer
33. Assessing clinical probability of pulmonary embolism in the emergency ward: A simple score